Enanta Pharmaceuticals
ENTA
#7451
Rank
HK$3.28 B
Marketcap
HK$113.66
Share price
3.62%
Change (1 day)
82.61%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Cash on Hand

Cash on Hand as of June 2025 : HK$1.58 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has HK$1.58 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Enanta Pharmaceuticals - Cash on Hand chart (from 2011 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30HK$1.92 B-33.4%
2023-09-30HK$2.89 B48.06%
2022-09-30HK$1.95 B2.98%
2021-09-30HK$1.89 B-36.6%
2020-09-30HK$2.99 B14.03%
2019-09-30HK$2.62 B8.73%
2018-09-30HK$2.41 B38.35%
2017-09-30HK$1.74 B7.2%
2016-09-30HK$1.62 B44.8%
2015-09-30HK$1.12 B59.68%
2014-09-30HK$0.70 B-10.46%
2013-09-30HK$0.78 B131.95%
2012-09-30HK$0.33 B86.69%
2011-09-30HK$0.18 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
AbbVie
ABBV
HK$44.14 B 2,678.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$144.49 B 8,994.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$48.94 B 2,980.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$141.78 B 8,823.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$128.46 B 7,984.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$75.92 B 4,678.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland